BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Zhu, Jing ^a   Sun, Li ^a   Lin, Sensen ^a   Zhao, Renping ^a   Zhou, Liqiang ^a   Fang, Dongdong ^a   Chen, Liang ^a   Liu, Jin ^a   Shi, Wenting ^a   Zhang, Luyong ^a   Yuan, Shengtao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

BLyS; Cell migration; Hypoxia

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; B CELL MATURATION ANTIGEN; TNFRSF13B PROTEIN, HUMAN; TNFRSF13C PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CELL HYPOXIA; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; TUMOR CELL LINE;

B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTOR RELA; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; UP-REGULATION;

EID: 84859067614     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-31     Document Type: Article

References (30)

1. BLyS and B cell homeostasis. Woodland RT, Schmidt MR, Thompson CB, Semin Immunol 2006 18 318 326 10.1016/j.smim.2006.06.001 16931037 (Pubitemid 44287557)
2. BAFF, APRIL and human B cell disorders. Tangye SG, Bryant VL, Cuss AK, Good KL, Semin Immunol 2006 18 305 317 10.1016/j.smim.2006.04.004 16916610 (Pubitemid 44287555)
3. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel K, Gross JA, Greipp PR, Jelinek DF, Blood 2004 103 689 694 10.1182/blood-2003-06-2043 14512299 (Pubitemid 38140105)
4. B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus. Parameswaran R, David HB, Sharabi A, Zinger H, Mozes E, Clin Immunol 2009 131 223 232 10.1016/j.clim.2008. 12.009 19188092
5. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Kalled SL, Semin Immunol 2006 18 290 296 10.1016/j.smim.2006.06.002 16931038 (Pubitemid 44382641)
6. Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas. Pelekanou V, Kampa M, Kafousi M, Darivianaki K, Sanidas E, Tsiftsis DD, Stathopoulos EN, Tsapis A, Castanas E, BMC Cancer 2008 8 76 10.1186/1471-2407-8-76 18366696 (Pubitemid 351583874)
7. Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Rosmorduc O, Housset C, Semin Liver Dis 2010 30 258 270 10.1055/s-0030-1255355 20665378
8. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappa B activation on desferrioxamine-stimulated HMC-1 cells. Jeong HJ, Chung HS, Lee BR, Kim SJ, Yoo SJ, Hong SH, Kim HM, Biochem Biophys Res Commun 2003 306 805 811 10.1016/S0006-291X(03)01073-8 12821113 (Pubitemid 36776202)
9. Inflammatory factors promote oral squamous cell carcinoma cells metastasis, via nuclear factor kappa B signal pathway in vitro. Yan M, He D, Zhang P, Zhou XJ, Chen WT, Zhonghua Kou Qiang Yi Xue Za Zhi 2010 45 146 151 20450681
10. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-kappa B. Huang G, Yang Y, Xu Z, Zhou P, Gong W, Li Y, Fan J, He F, Eur J Pharmacol 2011 650 451 457 10.1016/j.ejphar.2010.09.065 20950605
11. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. Pascal S, Fabienne M, Veronique S, Kay H, Jean LB, Nils H, Christine A, Pornsri L, Sarah B, Hans AO, Danila V, Pedro R, Christiane WF, Rudolph HZ, Jeffrey LB, Jurg T, J Exp Med 1999 189 1747 1758 10.1084/jem.189.11.1747 10359578 (Pubitemid 29272691)
12. TWE-PRIL: a fusion protein of TWEAK and APRIL. Geertruida MK, Berengere PB, Michael H, Jan PM, Biochem Pharmacol 2003 66 1427 1432 10.1016/S0006- 2952(03)00493-3 14555217 (Pubitemid 38373329)
13. BAFF-R promotes cell proliferation and survival through interaction with IKK-beta and NF-kappa B/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells. Fu L, Lin-Lee YC, Pham LV, Tamayo AT, Yoshimura LC, Ford RJ, Blood 2009 113 4627 4636 10.1182/blood-2008-10-183467 19258594
14. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T, Ageing Res Rev 2008 7 83 105 10.1016/j.arr.2007. 09.002 17964225 (Pubitemid 351418294)
15. Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma. Mohamed KM, Le A, Duong H, Wu Y, Zhang Q, Messadi DV, Exp Mol Pathol 2004 76 143 152 10.1016/j.yexmp.2003.10.005 15010293 (Pubitemid 38316929)
16. No inflammation? No cancer! Clear HBV early and live happily. Villa E, Fattovich G, J Hepatol 2010 52 768 770 10.1016/j.jhep.2010.01.018 20356646
17. Inflammation, a key event in cancer development. Lu H, Ouyang WM, Huang CS, Mol Cancer Res 2006 4 221 233 10.1158/1541-7786.MCR-05-0261 16603636
18. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappa B-Dependent Manner. Erez N, Truitt M, Olson P, Arron ST, Hanahan D, Cancer Cell 2010 17 135 147 10.1016/j.ccr.2009.12.041 20138012
19. Inflammatory signaling pathways in self-renewing breast cancer stem cells. Hinohara K, Gotoh N, Curr Opin Pharmacol 2010 10 650 654 10.1016/j.coph.2010.08.003 20817605
20. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. Lopez-Novoa JM, Nieto MA, EMBO Mol Med 2009 1 303 314 10.1002/emmm.200900043 20049734
21. IKK links inflammation and tumotigensis in a mouse model of colitis-associated cancer. Florian RG, Tim FG, Jin MP, Li ZW, Laurence JE, Martin FK, Michael K, Cell 2004 118 285 296 10.1016/j.cell.2004.07.013 15294155 (Pubitemid 39061110)
22. NF-kappa B as a molecular target in adjuvant therapy of gastrointestinal carcinomas. Yu YY, Li Q, Zhu ZG, Eur J Surg Oncol 2005 31 386 392 15837045 (Pubitemid 40521305)
23. Role of NF-B in thyroid cancer. Pacifico F, Leonardi A, Mol Cell Endocrinol 2009 321 29 35 19879919
24. Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappa B/HIF-1alpha activation. Gonzalez-Perez RR, Xu Y, Guo S, Watters A, Zhou W, Leibovich SJ, Cell Signal 2010 22 1350 1362 10.1016/j.cellsig.2010.05.003 20466060
25. NF-kappa B inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosis. Mi J, Zhang X, Liu Y, Reddy SK, Rabbani ZN, Sullenger BA, Clary BM, Biochem Biophys Res Commun 2007 359 475 480 10.1016/j.bbrc.2007.05.125 17560552 (Pubitemid 46898974)
26. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling. Scherbakov AM, Lobanova YS, Shatskaya VA, Krasil'nikov MA, Steroids 2009 74 535 542 10.1016/j.steroids. 2009.02.003 19428442
27. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF, Gross JA, Ansell SM, Blood 2004 104 2247 2253 10.1182/blood-2004-02- 0762 15251985 (Pubitemid 39331819)
28. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Ryu CH, Park SA, Kim SM, Lim JY, Jeong CH, Jun JA, Oh JH, Park SH, Oh WI, Jeun SS, Biochem Biophys Res Commun 2010 398 105 110 10.1016/j.bbrc.2010.06.043 20558135
29. The p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migration. Gamell C, Susperregui AG, Bernard O, Rosa JL, Ventura F, PLoS One 2011 6 16477 10.1371/journal.pone.0016477 21297993
30. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A, J Exp Med 2006 203 2551 2562 10.1084/jem.20060990 17060474 (Pubitemid 44664624)